long covid

Health systems across Long Island are turning their attention to the mental health of doctors, nurses and other staff in the aftermath of the COVID-19 pandemic. The story, reported by Newsday, highlights efforts by regional hospitals to address burnout and emotional strain among health care workers, a group heavily affected by pandemic working conditions.

New Phase 2 trial data has been released on Bezisterim as a potential treatment for long COVID, according to Psychiatric Times. The drug, an anti-inflammatory compound, is being studied for patients suffering from persistent symptoms after coronavirus infection. The findings are drawing attention as treatment options for long COVID remain limited and demand for effective therapies continues to grow.

Reports examine why the New Yalu River Bridge, meant to link China and North Korea across the Yalu River, took more than a decade to open after its construction was largely finished in 2014. Coverage attributes the repeated delays to North Korea's nuclear weapons tests, purges within its leadership, and the COVID-19 pandemic's border closures, which froze cross-border traffic between the two countries.

The advocacy organization Solve M.E. is pressing the CDC to continue including ME/CFS and Long Covid questions in the National Health Interview Survey, a key federal source of data on chronic illness in the United States. Supporters are being asked to add their voices, warning that removing these conditions would erase vital evidence about post-infectious disease burden.

A New York Times article on long Covid is circulating among health commentators, who highlight its warning that Covid can cause long-term damage to nearly every part of the body and that repeated infections can compound those harms. Commenters hope mainstream coverage will prompt more people to take the ongoing risks of infection seriously.

US CDC data on long COVID, published through its National Center for Health Statistics Household Pulse Survey and data briefs, is being highlighted as essential for understanding the public health burden of the ongoing pandemic on Americans. Commenters stress that these datasets and briefs, such as data brief db488, quantify how many people continue to suffer lasting symptoms and inform policy on the pandemic's long-term impact.

Researchers and health commentators are highlighting that infections account for roughly 12% of new cancer cases. Explanations vary by pathogen: HIV suppresses the immune system, allowing other carcinogenic viruses to replicate, while H. pylori damages stomach tissue in ways that can trigger cancer. Discussion also touches on whether Covid-19 could carry similar long-term risks, which remains unproven and is fueling debate.

Doctors say their main concern about repeated Covid infections is not the acute illness but the risk of developing long Covid, which can cause lasting damage to nearly every part of the body. The comment has struck a chord as reinfections become routine and public attention to the virus fades, renewing debate over how seriously repeat infections should be taken.

A large review of Long COVID research has identified mechanisms consistent with accelerated biological aging in young adults, including epigenetic and cellular changes more typical of older people. The paper also cites findings of SARS-CoV-2-specific T cells in 40% of people with Long COVID, suggesting persistent immune activity. Researchers say the work helps explain the broad, lasting symptoms reported by younger patients.

Researchers say they have identified why some people still cannot taste food long after a COVID-19 infection. The finding points to a biological explanation for persistent taste dysfunction, a lingering symptom reported by many patients since the pandemic began. Coverage so far is limited to the announcement, and details of the study and its implications have not yet been widely reported.